Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-058942)

Filing Details

Accession Number:: 0001209191-22-058942
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-29 16:30:15
Reporting Period:: 2022-11-25

Accepted Time:: 2022-11-29 16:30:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1533040	Phio Pharmaceuticals Corp.	PHIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1304395	J Robert Bitterman	C/O Phio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough MA 01752	Interim Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value	Acquisiton	2022-11-25	2,500	$0.42	68,326	No	4	P	Direct
Common Stock, $0.0001 Par Value	Acquisiton	2022-11-29	215	$0.40	68,541	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes shares of common stock underlying unvested restricted stock units.